Frank Kanniess

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, David C. Dale, James F. Donohue et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 251 citations

The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma

Kai-Michael Beeh, Frank Kanniess, Frank Wagner et al. · Journal of Allergy and Clinical Immunology · 2013 · 163 citations

Asthma, Allergy, Allergy Medicine +8

Association of depression and anxiety with health care use and quality of life in asthma patients

Antje Kullowatz, Frank Kanniess, Bernhard Dahme et al. · Respiratory Medicine · 2006 · 158 citations · Full text

Asthma, Family Medicine, Quality Of Life +10

In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation

D. Loppow, M.B. Schleiss, Frank Kanniess et al. · Respiratory Medicine · 2001 · 110 citations · Full text

Allergy, Inflammatory Lung Disease, Lung Inflammation +9

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

Martin Sebastian, Bernward Passlick, H. Friccius-Quecke et al. · Cancer Immunology Immunotherapy · 2007 · 98 citations · Full text

Radiation Oncology, Medicine, Immunology +12